Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer

Pathology Research and Practice

Volumn 212, Issue 8, 2016, Pages 690-695

  Wang, Weili ^a   Xing, Chungen ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Colorectal cancer; lncRNA; Metastasis; Prognosis; ZFAS1

Indexed keywords

LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG; ZINC FINGER ANTISENSE 1; LONG NON-CODING RNA ZFAS1, HUMAN; SMALL INTERFERING RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CLINICAL FEATURE; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; HCT116 CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PREDICTION; PRIMARY TUMOR; RECURRENCE FREE SURVIVAL; TUMOR INVASION; UPREGULATION; ANIMAL; CELL MOTION; COLORECTAL TUMOR; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; NUDE MOUSE; PATHOLOGY; PROGNOSIS; RNA INTERFERENCE; SURVIVAL RATE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RNA INTERFERENCE; RNA, LONG NONCODING; RNA, SMALL INTERFERING; SURVIVAL RATE; UP-REGULATION;

EID: 84991220819     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2016.05.003     Document Type: Article

References (17)

1. [1] Siegel, R., Ma, J., Zou, Z., Jemal, A., Cancer statistics, 2014. CA. Cancer J. Clin. 64 (2014), 9–29.
2. [2] Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jemal, A., Global cancer statistics, 2012. CA. Cancer J. Clin. 65 (2015), 87–108.
3. [3] Sana, J., Faltejskova, P., Svoboda, M., Slaby, O., Novel classes of non-coding RNAs and cancer. J. Transl. Med., 10, 2012, 103.
4. [4] Wang, K.C., Chang, H.Y., Molecular mechanisms of long noncoding RNAs. Mol. Cell 43 (2011), 904–914.
5. [5] Liang, W.C., Fu, W.M., Wong, C.W., Wang, Y., Wang, W.M., Hu, G.X., Zhang, L., Xiao, L.J., Wan, D.C., Zhang, J.F., Waye, M.M., The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget 6 (2015), 22513–22525.
6. [6] Nie, W., Ge, H.J., Yang, X.Q., Sun, X., Huang, H., Tao, X., Chen, W.S., Li, B., LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett. 371 (2016), 99–106.
7. [7] Liu, Y., Zhao, J., Zhang, W., Gan, J., Hu, C., Huang, G., Zhang, Y., lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Sci. Rep., 5, 2015, 10159.
8. [8] Shi, S.J., Wang, L.J., Yu, B., Li, Y.H., Jin, Y., Bai, X.Z., LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget 6 (2015), 11652–11663.
9. [9] Du, T., Zhang, B., Zhang, S., Jiang, X., Zheng, P., Li, J., Yan, M., Zhu, Z., Liu, B., Decreased expression of long non-coding RNA WT1-AS promotes cell proliferation and invasion in gastric cancer. Biochim. Biophys. Acta 1862 (2016), 12–19.
10. [10] Ji, Q., Liu, X., Fu, X., Zhang, L., Sui, H., Zhou, L., Sun, J., Cai, J., Qin, J., Ren, J., Li, Q., Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway. PLoS One, 8, 2013, e78700.
11. [11] Yin, D., He, X., Zhang, E., Kong, R., De, W., Zhang, Z., Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Med. Oncol., 31, 2014, 253.
12. [12] Krell, J., Frampton, A.E., Mirnezami, R., Harding, V., De Giorgio, A., Roca Alonso, L., Cohen, P., Ottaviani, S., Colombo, T., Jacob, J., Pellegrino, L., Buchanan, G., Stebbing, J., Castellano, L., Growth arrest-specific transcript 5 associated snoRNA levels are related to p53 expression and DNA damage in colorectal cancer. PLoS One, 9, 2014, e98561.
13. [13] Thorenoor, N., Faltejskova-Vychytilova, P., Hombach, S., Mlcochova, J., Kretz, M., Svoboda, M., Slaby, O., Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget 7 (2016), 622–637.
14. [14] Li, T., Xie, J., Shen, C., Cheng, D., Shi, Y., Wu, Z., Deng, X., Chen, H., Shen, B., Peng, C., Li, H., Zhan, Q., Zhu, Z., Amplification of long noncoding RNA ZFAS1 promotes metastasis in hepatocellular carcinoma. Cancer Res. 75 (2015), 3181–3191.
15. [15] Askarian-Amiri, M.E., Crawford, J., French, J.D., Smart, C.E., Smith, M.A., Clark, M.B., Ru, K., Mercer, T.R., Thompson, E.R., Lakhani, S.R., Vargas, A.C., Campbell, I.G., Brown, M.A., Dinger, M.E., Mattick, J.S., SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA 17 (2011), 878–891.
16. [16] Huang, Z., Wen, P., Kong, R., Cheng, H., Zhang, B., Quan, C., Bian, Z., Chen, M., Zhang, Z., Chen, X., Du, X., Liu, J., Zhu, L., Fushimi, K., Hua, D., Wu, J.Y., USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration. Int. J. Cancer 136 (2015), 1792–1802.
17. [17] Yin, Y., Zhang, B., Wang, W., Fei, B., Quan, C., Zhang, J., Song, M., Bian, Z., Wang, Q., Ni, S., Hu, Y., Mao, Y., Zhou, L., Wang, Y., Yu, J., Du, X., Hua, D., Huang, Z., miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A. Clin. Cancer Res. 20 (2014), 6187–6199.